Key Dates

Related Announcements

PAR-21-035 - Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trials Required)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the Other Clinical Trials-related Attachments subsection of the PHS Human Subjects and Clinical Trials Information in Application and Submission Information of Funding Opportunity Announcement (FOA) PAR-21-035, “Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trials Required)".

Therefore, the following section of PAR-21-035 has been modified:

Currently Reads:

Part 2. Full Text of Announcement

Section IV. Application and Submission Information

PHS Human Subjects and Clinical Trials Information

Study Record: PHS Human Subjects and Clinical Trials Information

All instructions in the SF424 (R&R) Application Guide must be followed.

Section 5 - Other Clinical Trials-Related Attachments

5.1 Other Clinical Trials-related Attachments

For applications that have the complete Clinical Trial Protocol available, submit the Clinical Trial Protocol as a single pdf that combines all clinical documents.

Provide a list of clinical trials that demonstrate their experiences in trial coordination over the last 5 years, without duplicating information in biosketches. A table must be provided as an attachment using the filename “Clinical Trial Experience." The table must also include the following for each trial listed: start and completion date; percent of target accrued; whether the trials reached completion; and, if applicable, the date of first publication.

Modified to Read (change shown in bold italics):

Part 2. Full Text Announcement

Section IV. Application and Submission Information

PHS Human Subjects and Clinical Trials Information

Study Record: PHS Human Subjects and Clinical Trials Information

All instructions in the SF424 (R&R) Application Guide must be followed.

Section 5 - Other Clinical Trials-Related Attachments

5.1 Other Clinical Trials-related Attachments

For applications that have the complete Clinical Trial Protocol available, submit the Clinical Trial Protocol as a single pdf that combines all clinical documents.

Applicants should provide a list of clinical trials that demonstrate their experiences in trial coordination over the last 5 years, without duplicating information in biosketches. The table should be provided as an attachment using the filename “Clinical Trial Experience." The table should also include the following for each trial listed: start and completion date; percent of target accrued; whether the trials reached completion; and, if applicable, the date of first publication.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

For cancer prevention, early detection, screening, and symptom management-related clinical trials, contact:
Brandy Heckman-Stoddard, Ph.D., M.P.H.
National Cancer Institute (NCI)
Telephone: 240-276-7048
Email: [email protected]

For cancer control and population sciences-related clinical trials, contact:
Susan Czajkowski, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5871
Email: [email protected]